Agilent Supports Cancer Research Center - - Chromatography Online
Agilent Supports Cancer Research Center

LCGC Europe eNews

Dr Ronald A. DePinho – president of the University of Texas MD Anderson Cancer Center (Texas, USA) – has received an Agilent Thought Leader Award. Agilent Technologies (California, USA) will provide financial support for personnel as well as instrumentation for the center.

The work of DePinho has resulted in the development of improved cancer detection methods and cancer drug development. His research group focuses broadly on basic-to-translational research programmes for brain, colorectal, pancreas and prostate cancers, as well as ageing and neuro-degeneration.

The award will support DePinho and his team in their research into reprogramming the metabolome at the initial stages of cancer. Specifically, the instrumentation will “enhance” the investigation of metabolic adaptions during the development of pancreatic cancer, according to Dr Guilio Draetta, director of the Institute for Applied Cancer Science.

Pancreatic cancer is a major concern of DePinho’s group because survival rates of patients have not significantly improved over the past two decades. Depinho said: “This technology will allow us to rapidly identify new targets that drive the formation, progression and maintenance of pancreatic cancer. Discoveries from this research will also lead to the development of effective early detection biomarkers and novel therapeutic interventions.”

Patrick Kaltenbach, Agilent VP and general manager of the Liquid Phase division, said, “We are proud to support Dr DePinho’s exciting translational research programme, which will make use of metabolomics and integrated biology workflows and solutions in biomarker discovery.”

Draetta added: “Armed with novel biomarkers, earlier diagnosis and treatment will be possible, leading to improved patient outcomes. Additional opportunities for novel therapeutic intervention will also emerge from this work.”

For more information please visit:


blog comments powered by Disqus
LCGC E-mail Newsletters
Global E-newsletters subscribe here:



Column Watch: Ron Majors, established authority on new column technologies, keeps readers up-to-date with new sample preparation trends in all branches of chromatography and reviews developments. LATEST: When Bad Things Happen to Good Food: Applications of HPLC to Detect Food Adulteration

Perspectives in Modern HPLC: Michael W. Dong is a senior scientist in Small Molecule Drug Discovery at Genentech in South San Francisco, California. He is responsible for new technologies, automation, and supporting late-stage research projects in small molecule analytical chemistry and QC of small molecule pharmaceutical sciences. LATEST: HPLC for Characterization and Quality Control of Therapeutic Monoclonal Antibodies

MS — The Practical Art: Kate Yu brings her expertise in the field of mass spectrometry and hyphenated techniques to the pages of LCGC. In this column she examines the mass spectrometric side of coupled liquid and gas-phase systems. Troubleshooting-style articles provide readers with invaluable advice for getting the most from their mass spectrometers. LATEST: Radical Mass Spectrometry as a New Frontier for Bioanalysis

LC Troubleshooting: LC Troubleshooting sets about making HPLC methods easier to master. By covering the basics of liquid chromatography separations and instrumentation, John Dolan is able to highlight common problems and provide remedies for them. LATEST: How Much Can I Inject? Part I: Injecting in Mobile Phase

More LCGC Columnists>>

LCGC North America Editorial Advisory Board>>

LCGC Europe Editorial Advisory Board>>

LCGC Editorial Team Contacts>>

Source: LCGC Europe eNews,
Click here